Itero Biopharmaceuticals, Inc.

The female infertility market could see a growth spurt like it hasn’t seen in almost 10 years if the range of follicle stimulating hormones in Phase III prove successful. At least five recombinant FSH

Just three years ago, Allergan PLC didn’t have a women’s health business, but with its latest string of acquisitions, it is now one of the leaders in the sector. Its Jan. 23 purchase of Belgium’s

A new name next year and much greater focus on international business will result from Allergan PLC ’s acquisition of Switzerland’s Watson , which closed Oct. 31. Starting in 2013, the new combine

The New Year’s Day announcement that Jeremy Levin, a former senior Bristol-Myers Squibb Co. executive would replace Shlomo Yanai, the current CEO of Teva Pharmaceutical Industries Ltd., in May i